title: [Primary detection of malignant mesothelioma of the tunica vaginalis testis using the BMA-120 monoclonal antibody].
abstract: Malignant mesothelioma of the tunica vaginalis testis is an extremely rare tumor, with only 40 cases previously described in the literature. Treatment consists of inguinal orchiectomy with close-follow up [1]. Asbestose exposure, trauma and hydrocele have been implicated as risk factors. We describe a histopathological examination with the BMA antibody (Behring, Marburg, Germany) and the Lu-5 antibody (Hoffmann-La Roche, Basel, Switzerland). Furthermore, we describe the patient's history and the management according to preceding reports in the literature.
authors.affiliation: Urologische Universitätsklinik, Ruhr-Universität Bochum, Marienhospital Herne.
authors.forename: C W
authors.initials: CW
authors.lastname: Biermann
authors.forename: H
authors.initials: H
authors.lastname: Moch
authors.forename: T C
authors.initials: TC
authors.lastname: Gasser
authors.forename: W
authors.initials: W
authors.lastname: de Riese
authors.forename: G
authors.initials: G
authors.lastname: Rutishauser
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000032:analysis*; D006801:Humans; D008297:Male; D008654:Mesothelioma / Q000473:pathology* / Q000601:surgery; D009919:Orchiectomy; D013736:Testicular Neoplasms / Q000473:pathology* / Q000601:surgery; D013737:Testis / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor
vernacular_title: Erstmaliger Nachweis eines malignen Mesothelioms der Tunica vaginalis testis mit Hilfe des mononuklearen Antikörpers BMA-120.